Continue Reading
Full article on CNBC
Inside the dealmaking that pushed Trump to reclassify pot, expand access
Market Intelligence Analysis
AI-Powered
Why This Matters
The Trump administration has reclassified pot and expanded access to CBD products, following a year-long industry push that combined lobbying, donations, and insider access. This move opens the door to a Medicare CBD pilot program. The dealmaking process suggests a significant shift in the US government's stance on cannabis.
Market Impact
Market impact analysis based on bullish sentiment with 68% confidence.
Sentiment
Bullish
AI Confidence
68%
Article Context
Note: This is a brief excerpt for context. Click below to read the full article on the original source.
Trump’s pot executive order follows a yearlong industry push blending lobbying, donations and insider access, opening the door to a Medicare CBD pilot.
Original article published by
CNBC
on December 20, 2025.
Analysis and insights provided by AnalystMarkets AI.
Analysis and insights provided by AnalystMarkets AI.